Any Anticoagulating Drug in Combination With an Oral NSAID
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Domain
Defining Attributes
Definition
Number of individuals who are long-term users of anticoagulating drugs with concomitant use of ≥ 1 prescription of NSAID.
Numerator
Number of individuals who are long-term users of anticoagulating drugs acenocoumarol (B01AA07) or warfarin (B01AA03) or phenprocoumon (B01AA04) or dabigatran (B01AE07) or rivaroxaban (B01AF01) or apixaban (B01AF02) or Edoxaban (B01AF03) with concomitant use of ≥ 1 prescription of NSAID (M01A or M01B). Note: individuals who are long-term users of anticoagulating drugs are defined as individuals who use >270 Defined Daily Doses (DDD) of the B01A codes listed
Denominator
Number of individuals who long-term users of ATC-codes acenocoumarol (B01AA07) or warfarin (B01AA03) or phenprocoumon (B01AA04) or dabigatran (B01AE07) or rivaroxaban (B01AF01) or apixaban (B01AF02) or Edoxaban (B01AF03). individuals who are long-term users of anticoagulating drugs are defined as individuals who use >270 Defined Daily Doses (DDD) of the B01A codes listed above. If prescribing database does not report DDD, derive indicator using >270 days of the B01A codes listed above.
Exclusions
Use of Risk Adjustment
Risk Adjustments
Stratifications
Collection and Reporting Attributes
Type of Data Collection
Data Collection Methods
OECD